Odegard Valerie 4
4 · Silverback Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Odegard Valerie
President and CSO
Transactions
- Award
Stock Option (right to buy)
2022-02-01+98,438→ 98,438 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (98,438 underlying) - Award
Common Stock
2022-02-01+16,406→ 16,406 total - Award
Stock Option (right to buy)
2022-02-01+49,875→ 49,875 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (49,875 underlying)
Footnotes (3)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F3]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.